Literature DB >> 16304333

High cessation rates of cigarette smoking in subjects with and without COPD.

Brigitte Willemse1, Ivonne Lesman-Leegte, Wim Timens, Dirkje Postma, Nick ten Hacken.   

Abstract

BACKGROUND/
OBJECTIVE: In general, smoking cessation programs have low success rates. We evaluated the effectiveness of a 1-year smoking cessation program. This program was part of a research project investigating the effects of smoking cessation. PARTICIPANTS: In this longitudinal study on the effects of 1 year of smoking cessation, 38 smokers with COPD or chronic bronchitis (mean age, 55 years; 20 men) and 25 healthy subjects (mean age, 50 years; 11 men) who smoked on average 22 cigarettes per day were recruited. METHODS AND
RESULTS: An experienced nurse and a researcher conducted an intensive nonpharmacologic smoking cessation program based on 15 group meetings of 8 to 10 participants. A uniquely high number of 16 COPD or chronic bronchitis patients (42%) and 17 healthy subjects (68%) did not smoke 1 year after stopping smoking.
CONCLUSION: We suggest that frequent and intensive motivational support in a research setting accounts for the high cessation rates.

Entities:  

Mesh:

Year:  2005        PMID: 16304333     DOI: 10.1378/chest.128.5.3685

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Smoking cessation in COPD causes a transient improvement in spirometry and decreases micronodules on high-resolution CT imaging.

Authors:  Jaideep Dhariwal; Rachel C Tennant; David M Hansell; John Westwick; Christoph Walker; Simon P Ward; Neil Pride; Peter J Barnes; Onn Min Kon; Trevor T Hansel
Journal:  Chest       Date:  2014-05       Impact factor: 9.410

2.  Effective smoking cessation interventions for COPD patients: a review of the evidence.

Authors:  Sophie Coronini-Cronberg; Catherine Heffernan; Michael Robinson
Journal:  JRSM Short Rep       Date:  2011-10-14

3.  Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation.

Authors:  Fikreta Grabcanovic-Musija; Astrid Obermayer; Walter Stoiber; Wolf-Dietrich Krautgartner; Peter Steinbacher; Nicole Winterberg; Arne Cornelius Bathke; Michaela Klappacher; Michael Studnicka
Journal:  Respir Res       Date:  2015-05-22

Review 4.  Role of Neutrophil Extracellular Traps in Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  Ting Liu; Fa-Ping Wang; Geng Wang; Hui Mao
Journal:  Chin Med J (Engl)       Date:  2017-03-20       Impact factor: 2.628

5.  Evaluation of smoking cessation treatment initiated during hospitalization in patients with heart disease or respiratory disease.

Authors:  Thaís Garcia; Sílvia Aline Dos Santos Andrade; Angélica Teresa Biral; André Luiz Bertani; Laura Miranda de Oliveira Caram; Talita Jacon Cezare; Irma Godoy; Suzana Erico Tanni
Journal:  J Bras Pneumol       Date:  2018 Jan-Feb       Impact factor: 2.624

Review 6.  Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century.

Authors:  Rafael Laniado-Laborín
Journal:  Int J Environ Res Public Health       Date:  2009-01-09       Impact factor: 3.390

7.  Experiences of tobacco smoking and quitting in smokers with and without chronic obstructive pulmonary disease-a qualitative analysis.

Authors:  Eva A M van Eerd; Mette Bech Risør; Carolien R van Rossem; Onno C P van Schayck; Daniel Kotz
Journal:  BMC Fam Pract       Date:  2015-11-04       Impact factor: 2.497

8.  Effectiveness of individual counseling for smoking cessation in smokers with chronic obstructive pulmonary disease and asymptomatic smokers.

Authors:  Juan Chen; Yan Chen; Ping Chen; Zhijun Liu; Hong Luo; Shan Cai
Journal:  Exp Ther Med       Date:  2013-12-27       Impact factor: 2.447

9.  A randomized controlled trial of group intervention based on social cognitive theory for smoking cessation in China.

Authors:  Pinpin Zheng; Fengxia Guo; Yue Chen; Yingying Fu; Tingting Ye; Hua Fu
Journal:  J Epidemiol       Date:  2007-09       Impact factor: 3.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.